Timber Pharmaceuticals, Inc. (TMBR)
| Market Cap | 25.67M |
| Revenue (ttm) | 856,456 |
| Net Income (ttm) | -1.34M |
| Shares Out | 36.66M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 640,554 |
| Open | 0.740 |
| Previous Close | 0.741 |
| Day's Range | 0.690 - 0.740 |
| 52-Week Range | 0.665 - 3.650 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About TMBR
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.
Financial Performance
Financial StatementsNews
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate t...
Basking Ridge, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the devel...
Timber Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
BASKING RIDGE, NJ, Sept. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the develo...
Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to ...
- Topline results expected to be announced in the fourth quarter of 2021 -
Best Penny Stocks to Buy Now? 3 to Watch This Week
Are these top penny stocks worth watching right now? The post Best Penny Stocks to Buy Now?
7 Hottest Penny Stocks to Pick Up Now
Penny stocks from companies that have reasonable business fundamentals. Stocks that can possibly provide multi-fold returns.
Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2021 Financial Results
BASKING RIDGE, NJ, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the develo...
7 Reddit Penny Stocks to Watch for Big Upside Ahead
If we've learned anything from the Reddit in January, it's not to underestimate them. These 7 Reddit penny stocks have good upsides.
Timber Pharmaceuticals Announces Adjournment of Annual Meeting
Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the develo...
Timber Pharma Shares Jump As Mid-Stage Skin Disorder Study With TMB-001 Concludes Enrollment Early
Timber Pharmaceuticals Inc (NYSE: TMBR) has completed enrollment in the Phase 2b CONTROL study evaluating TMB-001, a topical pharmaceutical composition of isotretinoin, for moderate to severe subtypes o...
Timber Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Con...
- Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021 -
Investing in Penny Stocks? Don't Before You Do These 3 Things
Before investing in penny stocks, take a look at these 3 things The post Investing in Penny Stocks? Don't Before You Do These 3 Things appeared first on Penny Stocks to Buy, Picks, News and Information ...
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results
BASKING RIDGE, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the develop...
Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of the Board of Directors
- Edward J. Sitar appointed as Lead Independent Director of the Board -
5 Reddit Penny Stocks Seeing the Most Chatter Thursday
It's never a dull day on the Reddit Penny Stocks subreddit and we're checking in to see what's being talked about the most today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared...
Timber Pharmaceuticals Sets Record Date for Annual Meeting of Shareholders and Provides Update on Its Annual Filings
Basking Ridge, NJ, April 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber” or the "Company"), a biopharmaceutical company focused on the devel...
Timber Pharmaceuticals Provides Business Update and Announces Year End 2020 Financial Results
50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace
Timber Pharmaceuticals' Development Partner, AFT Pharmaceuticals, Enters into Licensing Agreement for Pascomer® (TMB-...
- Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe -
Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study in Congenital Ichthyosis
- Study is Evaluating TMB-001 (Topical Isotretinoin) in Subtypes of Rare Genetic Keratinization Disorder
TMBR Stock: What to Know About Red-Hot Timber Pharmaceuticals
Timber Pharmaceuticals spiked more than 75% in trading today following a virtual life sciences conference this week. Trading volume in TMBR stock was up more than 1600% on the day.
Timber Pharmaceuticals Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference
WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the de...
7 Penny Stocks In a Make-or-Break Year
These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...
Timber Pharmaceuticals Appoints Alan Mendelsohn, M.D., as Chief Medical Officer
Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs
Timber Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for TMB-003 for the Treatment of Systemic Scler...
Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022